ERBB1 and ERBB2 have distinct functions in tumor cell invasion and intravasation

Dmitriy Kedrin1, Jeffrey Wyckoff, Pamela J Boimel

  • 1Department of Anatomy and Structural Biology and Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine, Bronx, New York, USA.

Abstract

Insights

Epidermal growth factor receptor (EGFR) and HER2 inhibition rapidly blocks breast cancer cell invasion and intravasation. This study differentiates the roles of EGFR and HER2 in metastasis, suggesting ERBB inhibition for broader anti-cancer strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metastasis

Background:

  • Epidermal growth factor receptor (EGFR, also known as ERBB1) and HER2 (ERBB2) are frequently overexpressed in aggressive breast cancers, correlating with poor patient prognosis.
  • While ERBB inhibitors are studied for tumor growth effects, ERBBs can promote malignancy independently of tumor growth.
  • ERBB signaling pathways play a critical role in cancer cell invasion and metastasis.

Purpose of the Study:

  • To investigate the effect of ERBB1 and ERBB2 inhibition on in vivo tumor cell motility and intravasation using clinically relevant small-molecule inhibitors.
  • To evaluate the potential of ERBB inhibitors in blocking key steps of cancer cell metastasis beyond tumor growth.

Main Methods:

  • Utilized in vivo mouse models of breast cancer, specifically mammary fat pad tumors.
  • Tested the effects of ERBB1 and ERBB2 inhibitors, including AC480, lapatinib, gefitinib (ERBB1 inhibitor), and AG825 (ERBB2 inhibitor), on tumor cell invasive properties.

Main Results:

  • Inhibition of both ERBB1 and ERBB2 rapidly suppressed tumor cell motility and intravasation within 3 hours.
  • ERBB1 inhibition (gefitinib) effectively reduced tumor cell motility and invasion but not intravasation.
  • ERBB2 inhibition (AG825) specifically and rapidly blocked intravasation.

Conclusions:

  • ERBB1 and ERBB2 inhibition demonstrate rapid efficacy in blocking critical tumor cell invasive properties.
  • This study provides the first differentiation of ERBB1 and ERBB2 contributions to in vivo tumor cell invasion and intravasation.
  • The findings suggest that ERBB inhibition can be a valuable strategy to impede cancer cell metastasis by targeting invasion and intravasation, in addition to tumor growth.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...